86 related articles for article (PubMed ID: 26805324)
1. [Efficacy of Postoperative Chemotherapy in Stage Ⅳ Colorectal Cancer with Perforation].
Onozawa H; Kumamoto K; Matsuzawa T; Ishiguro T; Sobajima J; Fukuchi M; Kumagai Y; Ishibashi K; Mochiki E; Ishida H
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2242-4. PubMed ID: 26805324
[TBL] [Abstract][Full Text] [Related]
2. [Problems in the Treatment of Stage Ⅲ Colorectal Cancer with Perforation].
Onozawa H; Kumamoto K; Matsuzawa T; Ishiguro T; Sobajima J; Fukuchi M; Kumagai Y; Ishibashi K; Mochiki E; Ishida H
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2245-7. PubMed ID: 26805325
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of oxaliplatin-based adjuvant chemotherapy in stage II and III colorectal cancer with perforation].
Onozawa H; Hatano S; Matsuzawa T; Kuwabara K; Ishiguro T; Sobajima J; Kumamoto K; Fukuchi M; Kumagai Y; Baba H; Ishibashi K; Mochiki E; Ishida H
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1749-51. PubMed ID: 25731317
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis.
Kim HR; Min BS; Kim JS; Shin SJ; Ahn JB; Rho JK; Kim NK; Rha SY
Oncology; 2011; 81(3-4):175-83. PubMed ID: 22057187
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study of postoperative intraperitoneal chemotherapy combined with systemic chemotherapy for serosa-involved colorectal cancer].
Lin CP; Chi P
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):257-60. PubMed ID: 19434533
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer surgery in portal hypertensive patients: does adjuvant oxaliplatin affect prognosis?
Madbouly KM; Hussein AM; Zeid A
Dis Colon Rectum; 2013 May; 56(5):577-85. PubMed ID: 23575396
[TBL] [Abstract][Full Text] [Related]
7. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
8. Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer.
Nakayama I; Suenaga M; Wakatsuki T; Ichimura T; Ozaka M; Takahari D; Shinozaki E; Chin K; Ueno M; Mizunuma N; Yamaguchi T
Cancer Chemother Pharmacol; 2015 Jul; 76(1):133-9. PubMed ID: 25994854
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis.
Kim MS; Chung M; Ahn JB; Kim CW; Cho MS; Shin SJ; Baek SJ; Hur H; Min BS; Baik SH; Kim NK
J Surg Oncol; 2014 Aug; 110(2):214-21. PubMed ID: 24668581
[TBL] [Abstract][Full Text] [Related]
10. Using preoperative UFT to predict sensitivity to fluoropyrimidines in colorectal cancer.
Fujii M
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):55-60. PubMed ID: 10442363
[TBL] [Abstract][Full Text] [Related]
11. [Tolerability of XELOX in postoperative adjuvant chemotherapy for colorectal cancer].
Matsuda C; Danno K; Miyazaki S; Fujitani K; Kubota M; Kawada J; Takagi M; Fukui A; Iwase K; Tanaka Y
Gan To Kagaku Ryoho; 2014 Jun; 41(6):743-7. PubMed ID: 25129086
[TBL] [Abstract][Full Text] [Related]
12. Acute colonic perforation associated with colorectal cancer.
Khan S; Pawlak SE; Eggenberger JC; Lee CS; Szilagy EJ; Margolin DA
Am Surg; 2001 Mar; 67(3):261-4. PubMed ID: 11270886
[TBL] [Abstract][Full Text] [Related]
13. The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
Ogata Y; Matono K; Sasatomi T; Ishibashi N; Ohkita A; Mizobe T; Ogo S; Ikeda S; Ozasa H; Shirouzu K
Cancer Chemother Pharmacol; 2006 May; 57(5):577-83. PubMed ID: 16133529
[TBL] [Abstract][Full Text] [Related]
14. Preoperative drainage using a transanal tube enables elective laparoscopic colectomy for obstructive distal colorectal cancer.
Yamada T; Shimura T; Sakamoto E; Kurumiya Y; Komatsu S; Iwasaki H; Nomura S; Kanie H; Hasegawa H; Orito E; Joh T
Endoscopy; 2013; 45(4):265-71. PubMed ID: 23322477
[TBL] [Abstract][Full Text] [Related]
15. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
Taïeb J; Artru P; Paye F; Louvet C; Perez N; André T; Gayet B; Hebbar M; Goebel FM; Tournigand C; Parc R; de Gramont A
J Clin Oncol; 2005 Jan; 23(3):502-9. PubMed ID: 15659495
[TBL] [Abstract][Full Text] [Related]
16. [Study of the Postoperative Adjuvant Chemotherapy with UFT/LV or Capecitabine for Stage III Colorectal Cancer].
Maruyama T; Yasuda K; Sako A; Ueda K; Okumura M
Gan To Kagaku Ryoho; 2016 Jan; 43(1):69-72. PubMed ID: 26809528
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected liver metastases from colorectal cancer.
Turan N; Benekli M; Koca D; Ustaalioglu BO; Dane F; Ozdemir N; Ulas A; Oztop I; Gumus M; Ozturk MA; Berk V; Kucukoner M; Uner A; Balakan O; Helvaci K; Ozkan S; Yilmaz U; Buyukberber S;
Oncology; 2013; 84(1):14-21. PubMed ID: 23076023
[TBL] [Abstract][Full Text] [Related]
18. [Final results of a randomized clinical trial of adjuvant intraportal chemotherapy for colorectal cancer: Intraportal Chemotherapy for Colorectal Cancer Group].
Yamamura T; Yabe K; Oka H; Kouzuma T; Kawahara H; Wakayama T; Sugiura A; Hagiwara M; Ohdate K; Miyajima N; Maeda C; Okamura R; Miyahara T; Moriyama Y; Yamaguchi S; Gunji A;
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1765-71. PubMed ID: 12402427
[TBL] [Abstract][Full Text] [Related]
19. The expression of vascular endothelial growth factor determines the efficacy of post-operative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer.
Ogata Y; Matono K; Mizobe T; Ishibashi N; Mori S; Akagi Y; Ikeda S; Ozasa H; Murakami H; Shirouzu K
Oncol Rep; 2006 May; 15(5):1111-6. PubMed ID: 16596171
[TBL] [Abstract][Full Text] [Related]
20. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G
Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
